1LIP G Y H. The prothrombotic state in atrial fibrillation: new insights, more guestions and clear answers needed. Am Heart J,2000, 140(3) : 348-350.
2Kamath S, Blann AD, Caine GJ. Platelet P-selectin levels in relation to plasma soluble P-selectin and β-thromboglobulin levels in atrial fibrillation. Stroke, 2002,33 (5) : 1237-1242.
3LI-SAW-HEE FL,Blann AD, Gumey D, et al. Plasma You Wilebrand factor, fibrinogen and soluble P-selectin levels in paroxysmal, persistent and permanent atrial fibrillation :effects of cardioversion and return of left atrial fibrillation. Eur Heart J,2001, 22 ( 18 ) : 1741 - 1747.
4Minamino T, Kitakaze M, Sanada S,et al. Increased expression of P-selectin on platelets is a risk factor for silent cerebral infarction in patients with atrial fibrillation. Circulation, 1998, 98 (17) : 1721-1727.
5LI-SAW-HEE FL, Blann AD,Lip GYH. A cross-sectional and diurnal study of thrombogenesis among patients with chronic atrial fibrillation. J Am Coll Cardio, 2000, 35 (19) : 1926-1931.
6Dwayne SG,Conway JH, Deirdre AM, et al. Atrial fibrillation and the prothrombotic state in the elderly. The Rotterdam Study. Stroke, 2003,34(2) : 413-417.
7Naab M, AL-Saady A J, Haven, et al. Vun Willebrand factor and tissue factors expressions increased in the atrial tissue of the fibrillating atrium. J Am Coll Cardiol, 2001, 37 (supplA) : 113A.
8Lip GYH, Blann AD. Von Willebrand factor: a marker of endothelial dysfunction in vascular disorders? Cardiovascular Research, 1997, 34 (2) :255-265.
9Heppell RM, Berkin KE, Mclenachan J M, et al. Haemostatic and haemodynamic abnormalities associated with left atrial thrombosis in nonrhumatic atrial fibrillation. Heart, 1997, 77(5): 407-411.
